Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Olufolake, Adisa"'
Autor:
Janet Figueroa, Harold K. Simon, Reshika D. Mendis, Claudia R. Morris, Adina Alazraki, Robert Hagbom, Sam Friedman, Shaminy Manoranjithan, Courtney McCracken, Stephen M. Russell, Stephanie G. Cohen, Olufolake Adisa, Zayir M Malik
Publikováno v:
Annals of Emergency Medicine. 76:S46-S55
Study objective Acute chest syndrome is a leading cause of mortality in patients with sickle cell disease (SCD). Because early detection of acute chest syndrome is directly tied to prognosis, young patients with SCD undergo countless chest radiograph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadf717c32551ed23116b6de7d0c2978
https://doi.org/10.1016/j.annemergmed.2020.08.012
https://doi.org/10.1016/j.annemergmed.2020.08.012
Autor:
Samit Ghosh, Fang Tan, Tianwei Yu, Yuhua Li, Olufolake Adisa, Mario Mosunjac, Solomon F Ofori-Acquah
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e18399 (2011)
Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion and ischemia reperfusion injury. These events cause endothelial dysfunction and vasculopathies in multiple systems. However, the lack of atherosclerotic lesions has led to the id
Externí odkaz:
https://doaj.org/article/344572c54fa7475dbbf0b6dabb63ba7f
Autor:
Miranda Bailey, Santosh L. Saraf, Olufolake Adisa, Laura Pastor, Wally R. Smith, Stephen Brown, Nicholas Ramscar, Ashley Bonner, Kenneth I. Ataga
Publikováno v:
Blood. 136:32-33
OBJECTIVES: Vaso-occlusion is a hallmark feature of sickle cell disease (SCD) that promotes ischemia-reperfusion injury and leads to acute pain episodes, known as vaso-occlusive crises (VOCs). VOCs are disabling and frequently impact on the ability o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f94b829c3e21c35987b65ff34c12f27
https://doi.org/10.1182/blood-2020-140428
https://doi.org/10.1182/blood-2020-140428
Autor:
Rodney Theodore, Vaughn Barry, Robert Clark Brown, Maa-Ohui Quarmyne, Wei Dong, Clinton H. Joiner, James Bost, Sonia Anand, Iris Buchanan, Olufolake Adisa, Peter A. Lane
Publikováno v:
American Journal of Hematology. 92:77-81
The clinical efficacy of hydroxyurea in patients with sickle cell anemia (SCA) has been well established. However, data about its clinical effectiveness in practice is limited. We evaluated the clinical effectiveness of hydroxyurea in a large pediatr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd8bc8ebc965cf4cc982b2ae20bbccb2
https://doi.org/10.1002/ajh.24587
https://doi.org/10.1002/ajh.24587
Publikováno v:
Annals of the American Thoracic Society. 14:475-477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efca7e61fbe415a3d0b8bcd68c792d11
https://doi.org/10.1513/annalsats.201608-626le
https://doi.org/10.1513/annalsats.201608-626le
Autor:
Amanda Watt, Deepika S. Darbari, Michael R. DeBaun, Barbara Speller-Brown, Zalaya K. Ivy, Olufolake Adisa, Shaina M. Willen, Suvankar Majumdar, Leah Vance Utset, Leann Schilling, Stefanie Pepper, Chantel L. Jenkins, Mark Rodeghier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9426fb65915ebabc383907bac58cfad5
https://europepmc.org/articles/PMC5842125/
https://europepmc.org/articles/PMC5842125/
Autor:
Samit Ghosh, Kesmic A Jackson, Prasanthi Chappa, Fang Tan, David R. Archer, Solomon F. Ofori-Acquah, Olufolake Adisa
Publikováno v:
Journal of Clinical Investigation. 123:4809-4820
The prevention and treatment of acute chest syndrome (ACS) is a major clinical concern in sickle cell disease (SCD). However, the mechanism underlying the pathogenesis of ACS remains elusive. We tested the hypothesis that the hemolysis byproduct hemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d2b73404e907ef5ba4b5fe68f01267
https://doi.org/10.1172/jci64578
https://doi.org/10.1172/jci64578
Publikováno v:
Respiratory Medicine ISBN: 9783319419107
Acute chest syndrome (ACS) is the major lung complication and leading cause of death in sickle cell disease (SCD). It is characterized by a rapid disease onset, pulmonary infiltration, hypoxemia, and several other clinical indications. Postmortem ACS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50d53af14ba1e1998ac0b4838b3830d8
https://doi.org/10.1007/978-3-319-41912-1_3
https://doi.org/10.1007/978-3-319-41912-1_3
Autor:
Sarah G, Lazarus, Michael, Kelleman, Olufolake, Adisa, April R, Zmitrovich, Robert, Hagbom, Stephanie, Cohen, Courtney E, McCracken, Claudia R, Morris
Publikováno v:
American journal of hematology. 91(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d4fcdcdb2edd52f9231c090398b9979
https://pubmed.ncbi.nlm.nih.gov/27153121
https://pubmed.ncbi.nlm.nih.gov/27153121
Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease
Autor:
Solomon F. Ofori-Acquah, Eldad A. Hod, Leslie S. Kean, James C. Zimring, Steven L. Spitalnik, Olufolake Adisa, David R. Archer, Jeanne E. Hendrickson, Samit Ghosh, Prasanthi Chappa, Jennifer Perry
Publikováno v:
Transfusion. 52:231-240
BACKGROUND: Increased rates of red blood cell (RBC) alloimmunization in patients with sickle cell disease may be due to transfusion frequency, genetic predisposition, or immune dysregulation. To test the hypothesis that sickle cell pathophysiology in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::346a4b95765d00c331eb1127fcf0c37e
https://doi.org/10.1111/j.1537-2995.2011.03255.x
https://doi.org/10.1111/j.1537-2995.2011.03255.x